Hudson Bay Capital Management
SLDB icon

Hudson Bay Capital Management’s Solid Biosciences SLDB Stock Holding History

Hudson Bay Capital Management’s Portfolio SLDB Stock Details SLDB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-12,650
Closed -$91.1K – 1662
2026
Q1 		$91.1K Buy
+12,650
New +$81.3K ﹤0.01% 1192
2018
Q4 		– Sell
-1,667
Closed -$1.18M – 912
2018
Q3 		$1.18M Sell
1,667
-666
-29% -$418K 0.01% 554
2018
Q2 		$1.25M Buy
+2,333
New +$718K 0.02% 604

Other funds holding SLDB

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Hudson Bay Capital Management's SLDB Position: Q2 2026 in Review

Hudson Bay Capital Management sold out of Solid Biosciences (SLDB) in Q2 2026, closing a stake of 12,650 shares — an estimated $91.1K sold.

Hudson Bay Capital Management first reported a position in SLDB in Q2 2018 and held it in 3 quarters. The position peaked at $1.25M in Q2 2018. 157 funds tracked by Wall St. Rank hold SLDB as of Q2 2026.

  • Hudson Bay Capital Management reported no remaining Solid Biosciences position as of Q2 2026 after selling out during the quarter.
  • Hudson Bay Capital Management sold 12,650 Solid Biosciences shares in Q2 2026, an estimated $91.1K.
  • Hudson Bay Capital Management first reported a position in Solid Biosciences in Q2 2018 and held it in 3 quarters.
  • Hudson Bay Capital Management's Solid Biosciences position peaked at $1.25M in Q2 2018.
  • 157 funds tracked by Wall St. Rank held Solid Biosciences as of Q2 2026.

Based on Hudson Bay Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.